Cressman, S., Karsan, A., Hogge, D., McPherson, E., Bolbocean, C., Regier, D., & Peacock, S. (2016). Economic impact of genomic diagnostics for intermediate‐risk acute myeloid leukaemia. Wiley.
Chicago-čujuhus (17. p.)Cressman, S., A. Karsan, DE Hogge, E. McPherson, C. Bolbocean, DA Regier, juo SJ Peacock. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
MLA-čujuhus (9. p.)Cressman, S., et al. Economic Impact of Genomic Diagnostics for Intermediate‐risk Acute Myeloid Leukaemia. Wiley, 2016.
Muitte dárkkistit čujuhemiid riektatvuođa, ovdal go geavahat daid iežat deavsttas.